Roth MKM Reaffirms Their Buy Rating on Oric Pharmaceuticals (ORIC)
I'm PortAI, I can summarize articles.
Roth MKM analyst reiterated a Buy rating on Oric Pharmaceuticals today and set a price target of $15.00.TipRanks Cyber Monday Sale Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off Currently, the analyst consensus on Oric Pharmaceuticals is a Strong Buy with an average price target of $19.33.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments